Back to News
Market Impact: 0.45

Whisky demand has dropped significantly in recent years, leaving liquor makers with a pile of unsold..

DEO
Consumer Demand & RetailPandemic & Health EventsInflationCompany FundamentalsCorporate EarningsTrade Policy & Supply ChainBanking & LiquidityCorporate Guidance & Outlook
Whisky demand has dropped significantly in recent years, leaving liquor makers with a pile of unsold..

Major listed spirits producers have accumulated about $22bn of aged inventory — the highest in a decade — after ramping production during COVID-19 while consumer demand has since fallen due to inflation and well‑being trends. Remy Cointreau’s aging stock is €1.8bn (nearly double its annual sales and close to market cap) and Diageo holds $8.6bn of aged whiskey; Diageo’s debt/EBITDA is 3.4x, above its <3x target. Companies are cutting or suspending production and disposing stock, raising balance‑sheet and margin risks and increasing the probability of price cuts that could pressure sector earnings and valuations.

Analysis

Market structure: Inventory = ~$22bn across majors, with DEO holding ~$8.6bn and RCO ~€1.8bn, signalling acute oversupply and material carrying costs. Losers are high-inventory, high-leverage spirits majors (Diageo/DEO, Rémy) facing margin compression and potential price wars; winners include large discount retailers, private-label/low‑alcohol brands, and potential acquirers with dry powder. Cross-asset: expect widening credit spreads on BBB/BB-rated liquor debt, higher equity implied volatility, modest downward pressure on GBP/EUR if exports slump, and a small softening in grains/corn demand. Risk assessment: Tail risks include (A) deep demand collapse → significant inventory impairments and covenant breaches within 6–12 months, and (B) sharp demand rebound (China/US travel) → supply shortages in 5–10 years if cuts persist. Immediate (days–weeks): elevated headline risk around quarterly reports; short-term (3–12 months): margin squeeze and production curbs; long-term (3–10 years): structural reshaping via closures and possible scarcity-driven repricing. Hidden dependencies: aged-stock valuations tied to future pricing, FX, and interest rates (carrying cost), and obesity-drug adoption pacing. Trade implications: Tactical short bias on DEO: consider a defined-risk 12‑month put spread (25–35% OTM) sized 1–2% portfolio targeting 15–25% downside if inventory impairments surface; pair trade: short DEO, long LVMH (MC.PA) 0.5–1% for luxury diversification. Credit: buy CDS or underweight senior bonds if DEO spread widens >150–200bps. Rotate into high-quality staples (KO, PG) and no‑/low‑alcohol ETFs; act within 2–6 weeks ahead of earnings and trim positions if net-debt/EBITDA <3.0x or inventory/sales <40%. Contrarian angles: The market may over-index to a secular decline while ignoring the 5–10 year supply lag—today’s cuts can create scarcity and price power later; historical parallel: 1980s whisky crash then multi-decade rerating. The sell-off could be overdone if equity falls >20% without real impairments; unintended consequences include opportunistic M&A (LVMH/Conso buyers) — set opportunistic buy triggers (e.g., LVMH down >10% or DEO impairment >5% sales).